Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms

por Kangaspeska, Sara, Hultsch, Susanne, Edgren, Henrik, Nicorici, Daniel, Murumägi, Astrid, Kallioniemi, Olli
Publicado 2012

Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR Inhibitors

por Jacome Sanz, Dafne, Raivola, Juuli, Karvonen, Hanna, Arjama, Mariliina, Barker, Harlan, Murumägi, Astrid, Ungureanu, Daniela
Publicado 2021

STRN-ALK rearranged pediatric malignant peritoneal mesothelioma – Functional testing of 527 cancer drugs in patient-derived cancer cells

por Murumägi, Astrid, Ungureanu, Daniela, Arjama, Mariliina, Bützow, Ralf, Lohi, Jouko, Sariola, Hannu, Kanerva, Jukka, Koskenvuo, Minna, Kallioniemi, Olli
Publicado 2021

Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1

por Meager, Anthony, Visvalingam, Kumuthini, Peterson, Pärt, Möll, Kaidi, Murumägi, Astrid, Krohn, Kai, Eskelin, Petra, Perheentupa, Jaakko, Husebye, Eystein, Kadota, Yoshihisa, Willcox, Nick
Publicado 2006

High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma

por Kohtamäki, Laura, Arjama, Mariliina, Mäkelä, Siru, Ianevski, Philipp, Välimäki, Katja, Juteau, Susanna, Ilmonen, Suvi, Ungureanu, Daniela, Kallioniemi, Olli, Murumägi, Astrid, Hernberg, Micaela
Publicado 2021

Identification of fusion genes in breast cancer by paired-end RNA-sequencing

por Edgren, Henrik, Murumagi, Astrid, Kangaspeska, Sara, Nicorici, Daniel, Hongisto, Vesa, Kleivi, Kristine, Rye, Inga H, Nyberg, Sandra, Wolf, Maija, Borresen-Dale, Anne-Lise, Kallioniemi, Olli
Publicado 2011

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors

por Kolberg, Matthias, Bruun, Jarle, Murumägi, Astrid, Mpindi, John P., Bergsland, Christian H., Høland, Maren, Eilertsen, Ina A., Danielsen, Stine A., Kallioniemi, Olli, Lothe, Ragnhild A.
Publicado 2017

ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity

por Piki, Emilia, Dini, Alice, Raivola, Juuli, Salokas, Kari, Zhang, Kaiyang, Varjosalo, Markku, Pellinen, Teijo, Välimäki, Katja, Veskimäe, Kristina Tabor, Staff, Synnöve, Hautaniemi, Sampsa, Murumägi, Astrid, Ungureanu, Daniela
Publicado 2023

Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness

por Karvonen, Hanna, Arjama, Mariliina, Kaleva, Laura, Niininen, Wilhelmiina, Barker, Harlan, Koivisto-Korander, Riitta, Tapper, Johanna, Pakarinen, Päivi, Lassus, Heini, Loukovaara, Mikko, Bützow, Ralf, Kallioniemi, Olli, Murumägi, Astrid, Ungureanu, Daniela
Publicado 2020

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

por Yadav, Bhagwan, Pemovska, Tea, Szwajda, Agnieszka, Kulesskiy, Evgeny, Kontro, Mika, Karjalainen, Riikka, Majumder, Muntasir Mamun, Malani, Disha, Murumägi, Astrid, Knowles, Jonathan, Porkka, Kimmo, Heckman, Caroline, Kallioniemi, Olli, Wennerberg, Krister, Aittokallio, Tero
Publicado 2014

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention

por Raivola, Juuli, Dini, Alice, Karvonen, Hanna, Piki, Emilia, Salokas, Kari, Niininen, Wilhelmiina, Kaleva, Laura, Zhang, Kaiyang, Arjama, Mariliina, Gudoityte, Greta, Seashore-Ludlow, Brinton, Varjosalo, Markku, Kallioniemi, Olli, Hautaniemi, Sampsa, Murumägi, Astrid, Ungureanu, Daniela
Publicado 2022

Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling

por Brunen, Diede, García-Barchino, María José, Malani, Disha, Basheer, Noorjahan Jagalur, Lieftink, Cor, Beijersbergen, Roderick L., Murumägi, Astrid, Porkka, Kimmo, Wolf, Maija, Zwaan, C. Michel, Fornerod, Maarten, Kallioniemi, Olli, Martínez-Climent, José Ángel, Bernards, René
Publicado 2016

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma

por Murumägi, Astrid, Ungureanu, Daniela, Khan, Suleiman, Arjama, Mariliina, Välimäki, Katja, Ianevski, Aleksandr, Ianevski, Philipp, Bergström, Rebecka, Dini, Alice, Kanerva, Anna, Koivisto-Korander, Riitta, Tapper, Johanna, Lassus, Heini, Loukovaara, Mikko, Mägi, Andrus, Hirasawa, Akira, Aoki, Daisuke, Pietiäinen, Vilja, Pellinen, Teijo, Bützow, Ralf, Aittokallio, Tero, Kallioniemi, Olli
Publicado 2022

Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes

por Kisand, Kai, Link, Maire, Wolff, Anette S. B., Meager, Anthony, Tserel, Liina, Org, Tõnis, Murumägi, Astrid, Uibo, Raivo, Willcox, Nick, Trebušak Podkrajšek, Katarina, Battelino, Tadej, Lobell, Anna, Kämpe, Olle, Lima, Kari, Meloni, Antonella, Ergun-Longmire, Berrin, Maclaren, Noel K., Perheentupa, Jaakko, Krohn, Kai J. E., Scott, Hamish S., Husebye, Eystein S., Peterson, Pärt
Publicado 2008